A desk with open books, printed research and a tablet

Education and understanding around opioids

A clearer conversation
about opioids.

Understand the ideas. Explore the evidence. Choose where to begin.

How to read this site

Not every statement here
carries the same weight.

Each piece of information is labelled, so it is always clear what published research has reported, what is our reading of it, and what is still an open question.

01

Published research

Findings reported in peer-reviewed scientific literature, with the source given in full.

Published research
02

SGR interpretation

Our reading of that literature, and what we believe it may suggest.

SGR interpretation
03

SGR research question

What we are asking. These are open questions, not answers.

Research question
04

Data not yet collected

Planned analysis. No results exist for this yet.

Data pending

Start here

Start with the
questions you have.

Explore clear, practical information on opioids, testing and the bigger picture — at your own pace.

Read the guides
A person reading printed guides at a table

Understanding the basics

Plain-language explanations of key topics related to opioids and genetic testing.

Read the guides

Reading the evidence

A closer look at the research and the supporting information behind it.

Explore the evidence

Questions to take further

Helpful questions to discuss with a qualified healthcare professional.

See the questions

Evidence library

Every source,
in one place.

Research articles, regulatory documents and supporting analysis — each one labelled, and open to read in full.

How to read this library
Open academic journals and printed research papers on a desk
All sources Published research Regulatory record SGR analysis Data and charts Supply chain
SGR analysis
Article one

Buprenorphine for the stabilization of the primary neurotoxicity secondary to opioid genotoxicity

An examination of stabilisation in the context of neurotoxic effects that may follow opioid-related genetic damage.

Smith Genetic Research · Date to be confirmed

SGR analysis
Article two

Part 2: Two separate and distinct populations

An analysis proposing two separate and distinct populations among opioid-exposed individuals, with differing biological profiles.

Smith Genetic Research · Date to be confirmed

SGR analysis
Article three

Part 3: Naming the genotoxicity and the 133,805 patient-day datapoints

A closer look at possible genotoxic effects of opioid exposure, drawing on 133,805 patient-day datapoints.

Smith Genetic Research · Date to be confirmed

Data pending
Charts

Estimated and projected cardiovascular deaths associated with opioid withdrawal

Two charts: estimates through 2019, and projections through 2024. These are an analysis of publicly available data, not an established outcome.

Underlying figures to be confirmed before publication

Regulatory record
Public record

The supply chain record

The documentary record behind opioid raw-material sourcing and import, drawn from government publications and official filings.

Public record · Every source listed in full on the page

Browse the full library
A tablet showing a simple hand-drawn explainer diagram

Visual learning

Pause. Revisit.
Understand.

Follow a visual explanation at your own pace, or read the written transcript instead.

Visual guide  ·  Captions  ·  Transcript

Open the visual guide

The project

A project built
around understanding.

Smith Genetic Research brings together written explanations, visual learning and supporting context.

  • 1
    Education

    Clear, accessible information.

  • 2
    Understanding

    A broader view of the issues.

  • 3
    Informed participation

    Resources to help you take the next step.

Dr. Douglas R. Smith

Live sessions

Short open sessions,
three times a week.

Dr. Doug Smith holds brief open sessions where the research and the evidence are discussed. Anyone can join, and every session is recorded.

Monday, Wednesday and Friday

12:30 – 12:45 PM ET

About fifteen minutes. No registration needed.

Join the next session Add to calendar
A laptop on a desk during an online session

This week

Epigenetic change and opioid exposure

What current research reports about DNA methylation and opioid exposure, and what it may mean for further study.

See the article being discussed
Session

The citizen petition process

How the petitions were prepared, and what happens next.

Watch
Session

Questions and answers

Questions raised by people following the research.

Watch
Session

Reading the evidence

How to approach the published literature behind the project.

Watch
Browse all previous sessions

Testing information

Understand the test
before taking the next step.

Learn what the test can and cannot tell you, so you can have an informed conversation with a healthcare professional.

Intended use

What the test is designed to look at.

Process

How the sample is collected and handled.

Limitations

What the test does not tell you.

Professional guidance

Why results should be discussed with a qualified professional.

Explore testing information

Taking part

Be part of
the evidence.

A larger dataset makes a clearer picture possible. Taking part is voluntary, and everything it involves is set out before anyone decides.

An at-home sample collection kit on a desk
1
Register interest
2
Eligibility check
3
Consent
4
Collection kit
5
Sample return
6
Laboratory processing
7
Research follow-up
The collection kit, the laboratory, the turnaround time, and whether individual results are returned are still being confirmed with the research team.

What the study examines

  • Potential genetic changes associated with opioid exposure
  • Potential epigenetic changes, including DNA methylation
  • Whether measurable biological markers can be identified
  • Patterns that may differ between exposed and non-exposed groups

What this does not establish

  • It is not a medical diagnosis
  • It does not determine whether anyone is addicted to opioids
  • It does not prove that any individual was harmed by opioid exposure
  • It cannot predict a person's future health
How results are used. Taking part is self-funded at $220 — a contribution towards sample collection, laboratory analysis and data processing. Participants may choose to share their results with their Congressional Representative and Senator in support of the proposed Bill. This is explained again in full in the consent form before anyone takes part.
Register your interest Read the research first
A government building seen from the street

The proposed Bill

From understanding
to informed participation.

Learn what the Bill proposes, and how to contact your Congressional Representative or Senator about it.

Explore the proposed Bill Ways to take action

Stabilising care

The Bill proposes stabilising care while further research continues.

Supporting research

It creates a pathway for further investigation into potential treatments.

Taking action

Readers can use their own voice to contact their representatives.

Before you begin

A few helpful answers.

Where should I start?

Begin with the written guides if you prefer to read, or the visual guide if you would rather watch. Both cover the same ground.

Who is this website for?

It is for individuals and families affected by opioid use, as well as clinicians, journalists and anyone following the research.

What should I know about testing?

The testing information section sets out what the test examines, what it does not establish, and why results should be discussed with a qualified professional.

Where can I find supporting sources?

Every source is listed in the evidence library, labelled by type so you can see what is published research and what is our own analysis.

Choose one question. Start there.

Start learning